Research & Development

Strong R&D has been at the core of the SMS growth since its inception. SMS started R&D activities with 4 Doctorate scientists supported by 20 senior chemists in a 10000 sq.ft area located in Sanathnagar. The R&D center is mainly focusing on anti-cancer, anti-migraine, anti diabetic, anti-ulcer, important intermediates and natural plant extracts. Development of non-infringing routes and cost effective alternative routes is the strength of the SMS Research Center. R&D at SMS drives the company’s competitive edge, reflected in the introduction of pioneering products and processes with a superior price-value proposition. Strong R&D has been at the core of SMS growth since its inception. SMS started R&D activities with 4 doctorate scientists supported by 20 senior chemists in a 10000 sq.ft area. SMS recently expanded its R&D facilities by creating a state of art corporate research center with infrastructure and expertise to carry out all the activities from product conception to the development, scale up, stability studies culminating in preparation of the DMF. SMS research team now comprises of about 100 scientists with expertise in process research, analytical research and scale up. A dedicated project management team handles costing, administration, purchase, and project monitoring. R&D capabilities of the company span across reaction technologies, organic compound categories, and novel catalytic systems. This center is capable of delivering top notch contract research modules to international clientele.

SMS R&D strategy is four pronged

1. Continuous research on cost optimization and process improvement for commercialized Products One R esearch Group at Sanathnagar R&D always working on cost optimization and reduction for commercialized Products. Best example being Ranitidine. The process has been optimized from 11 steps to present 3 steps. Similarly worked on Sumatriptan Succinate and Gemicitabine One research group at the R&D center is continuously working on cost optimization for commercialized products. Best example being Ranitidine. The ongoing focus on cost optimization helped SMS tackle competition and emerge a leader. Similar success was achieved in Sumatriptan Succinate and Gemicitabine 2. Development of non infringing and cost effective process for products nearing patent expiry Products are strategically selected based on the patent expiry and market conditions. Research groups work on development of non-infringing and cost effective processes. Successful products are scaled up and commercialized in non regulatory markets and ready for launch into regulated markets immediately upon patent expiry. 3. NCE Research and development up to pre clinical stage Ongoing NCE research work in Diuretic and Antidepressant therapeutic segment. Found to be very promising in the preliminary studies. Toxicity studies in progress. SMS will sell promising NCE to multinationals for further clinical studies and development 4 . Providing contract research services to pharma majors Successful track record in executing numerous contract research assignments for top notch companies